Historic national lawsuit settlements with pharmaceutical companies accused of fueling the opioid crisis will bring millions ...
A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.
A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.
The owners of Purdue Pharma, which makes OxyContin, have agreed to pay US7.4 billion ($11.7 billion) to settle ... opioid crisis, replaces a previous settlement that was rejected last year by the ...
BOSTON — Massachusetts and other states have reached a tentative $7.4 billion settlement with the Sackler family and Purdue Pharma over their alleged role in fueling the nation’s opioid crisis.
New York Attorney General Letitia James announced the settlement agreement on Thursday, but it must be approved in federal court. "Purdue, under the Sacklers' leadership, invented, manufactured and ...
"The Sacklers no longer have control of Purdue [Pharma] and will never be allowed to sell opioids in the United States again." She said the settlement won't cover the costs of all harm caused by ...
have increased their cash offer to settle the litigation — but with a novel catch. Under the framework for a new deal, the Sacklers would not receive immunity from future opioid lawsuits ...
The new settlement does not have that protection. Although opioid addiction is a problem nationwide, Virginia has played a significant role in the lawsuits against Purdue and McKinsey & Co., which ...
This settlement would resolve the action, according to Busse. Between 2002 and 2015, the number of opioid prescriptions dispensed in Utah increased by more than 1 million. From 2013 to 2015 ...